Predicting postoperative PPM and its real clinical consequences
Dr. Alisson Duncan
MVT Aortic 2022, vol.1
– PPM can be predicted and therefore, prevented
– How can we measure, normalize, and standardize various PPM-related assessments and risks?
– Make sure to consider the body surface area in relation to the transvalvular gradient, especially during physical activity or exercise
Prof. Augusto D’Onofrio
MVT Aortic 2022, vol.1
– Not only about hemodynamics, this lecture provides comparisons among three bioprostheses
– Similar clinical outcomes, better hemodynamic results, and shorter ICU stays for rapid deployment valves… but newer bioprosthesis tissue technology may raise the bar even higher
Prof. Alessandro Della Corte
MVT Aortic 2022, vol.1
– Patients with an “ascending” phenotype? A separate vale and ascending graft replacement procedure is an option
– Patients with a “root” phenotype? Consider addressing the root earlier (50 mm root diameter)
– Bentall is still the gold standard, but valve-sparing procedures have similarly good results
Prof. Ruggero De Paulis
MVT Aortic 2022, vol.1
– First and foremost, not all bicuspid aortic valves are the same
– Many post-operative measurements and goals are included within to help guide you to optimal patient outcomes
– Check out the insight provided about valve-sparing, valve repair, external annuloplasty, and more
Prof. Alessandro Della Corte
MVT Aortic 2022, vol.1
– New classification system and nomenclature of bicuspid aortic valve (and bicuspid aortic valve disease)
– Genes are important, but a single gene may contribute to fewer than 1% of cases
– Different valve repair techniques according to valve phenotype
Prof. Marjan Jahangiri
MVT Aortic 2022, vol.1
– Pay attention to comorbidities, the anticoagulation choice may not as simple as it seems
– Be aware of the limitations of the currently available studies, question them in a logical manner
Prof. Joseph Bavaria
MVT Aortic 2022, vol.1
Prof. Michael Borger
MVT Aortic 2022, vol.1
-The “aortic size paradox”: an interesting paradox, indeed
-Length? Diameter? Which should we pay more attention to?
-Be sure to pay attention to genetics, biomarkers, abnormal flow, other risk factors, and more
Prof. Friedhelm Beyersdorf
MVT Aortic 2022, vol.1
– Guidelines: based on scientific data, not an individual hospital’s, country’s, or region’s practices.
– It’s important to truly understand the recommendations and evidence classifications.
–Pay attention to the details in phrasing.
Prof. Bart Meuris
MVT Aortic 2022, vol.1
- Shorter hospital stays, less anticoagulation, long-term financial savings? Hear about the data of an expert’s personal experience.
- With advanced anti-calcification treatment, the future of bioprostheses is promising not only for patient outcomes, but even from a financial perspective
Dr. Douglas Johnston
STS annual meeting 202
Insights from INDURE registry
Prof. Ruggero De Paulis
Virtual Industry Symposium
Prof. Suwalski – MVT Intermediate 2021
Prof. Solinas – MVT Intermediate 2021
Prof. Falk – MVT Intermediate 2021
Dr. Farber – MVT Intermediate
Dr. Pasic – MVT Intermediate 2021
Prof. Benussi – MVT Intermediate 2021
Dr. Alison Duncan – MVT Intermediate 2021
